Table 2.
Prognostic value of clinicopathologic and image parameters in predicting disease-free survival using univariate and multivariate Cox models
| Variables | TNBC patients univariate Cox |
Subgroup TNBC patients with pre-treatment PET/CT univariate Cox |
Subgroup TNBC patients with pre-treatment PET/CT multivariate Cox |
|||
|---|---|---|---|---|---|---|
| HR (95 % CI) | p value | HR (95 % CI) | p value | HR (95 % CI) | p value | |
| TNM, pT stage, <3 versus ≥3 | 2.724 (1.198–6.193) | 0.017 | 1.786 (0.603–5.294) | 0.295 | 2.337(0.428–7.384) | 0.148 |
| TNM, pN stage, <1 versus ≥1 | 2.001 (1.010–3.696) | 0.047 | 1.999(0.774–5.163) | 0.153 | – | – |
| TNM, pM stage, =0 versus >0 | 3.503 (1.387–8.848) | 0.008 | 5.751 (1.292–25.61) | 0.022 | – | – |
| Ki-67 % continuous | 1.009 (0.996–1.022) | 0.156 | 1.012 (0.992–1.032) | 0.248 | – | – |
| ≤50 % versus >50 % | 1.689 (0.592–2.941) | 0.064 | 1.710 (0.756–3.866) | 0.197 | – | – |
| EGFR % continuous | 1.010 (1.001–1.019) | 0.039 | 1.039 (1.020–1.057) | ≪0.001 | – | – |
| ≤15 % versus >15 % | 3.612 (1.418–7.253) | 0.004 | 12.05 (2.793–52.01) | <0.001 | 9.109 (1.997–41.55) | 0.004 |
| CK5/6 % continuous | 1.007 (0.997–1.017) | 0.101 | 1.008 (0.992–1.022) | 0.055 | – | – |
| ≤50 % versus >50 % | 2.201 (1.142–4.242) | 0.018 | 2.959 (1.282–6.829) | 0.011 | 1.471 (0.598–3.614) | 0.401 |
| SUVmax continuous | – | – | 1.053 (1.008–1.101) | 0.021 | – | – |
| ≤3.5 versus >3.5 | – | – | 5.490 (1.629–18.51) | 0.006 | 3.883(1.13–13.32) | 0.031 |
| SUVmean continuous | – | – | 1.279 (1.109–1.474) | <0.001 | – | – |
| ≤2.9 versus >2.9 | – | – | 3.677 (1.488–9.087) | 0.005 | – | – |
| SUVvol continuous | – | – | 1.013 (1.000–1.030) | 0.012 | – | – |
| ≤10 ml versus >10 ml | – | – | 3.919 (1.737–8.843) | 0.001 | – | – |